BREAKING NEWS

Roche extends offer for Spark until Nov. 25

Euronews logo
Text size Aa Aa

ZURICH (Reuters) – Roche <ROG.S> said it extended its tender offer for shares of Spark Therapeutics, Inc. <ONCE.O> until Nov. 25 to give the U.S. Federal Trade Commission (FTC) and the UK Competition and Markets Authority (CMA) more time to complete their reviews of the $4.3 billion deal.

The parties remain committed to the transaction and are working cooperatively and expeditiously with the FTC and the CMA, Roche and Spark said in a joint statement on Tuesday.

The UK competition watchdog had launched an inquiry into the pending acquisition earlier this month.

(Reporting by Silke Koltrowitz, editing by Riham Alkousaa)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.
Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.